Mitochondrial dynamics and quality control in Huntington's disease

Neurobiology of Disease

Volumn 90, Issue , 2016, Pages 51-57

  Guedes Dias, Pedro ^a,b   Pinho, Brígida R ^a   Soares, Tânia R ^a   de Proença, João ^a   Duchen, Michael R ^b   Oliveira, Jorge M A ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Huntingtin; Huntington's disease; Mitochondria; Mitochondrial dynamics; Mitophagy

Indexed keywords

HUNTINGTIN; POLYGLUTAMINE;

AUTOPHAGOSOME; AUTOPHAGY; BRAIN NERVE CELL; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CORPUS STRIATUM; DEGENERATIVE DISEASE; GENE MUTATION; GENETIC DISORDER; HUMAN; HUNTINGTON CHOREA; MITOCHONDRIAL BIOGENESIS; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL QUALITY CONTROL; MITOCHONDRION; MITOPHAGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REVIEW; ANIMAL; METABOLISM; PHYSIOLOGY;

ANIMALS; HUMANS; HUNTINGTON DISEASE; MITOCHONDRIA; MITOCHONDRIAL DYNAMICS;

EID: 84945395398     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2015.09.008     Document Type: Review

References (109)

1. Amadoro G., Corsetti V., Florenzano F., Atlante A., Bobba A., Nicolin V., Nori S.L., Calissano P. Morphological and bioenergetic demands underlying the mitophagy in post-mitotic neurons: the pink-parkin pathway. Front. Aging Neurosci. 2014, 6:18.
2. Arrasate M., Mitra S., Schweitzer E.S., Segal M.R., Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 2004, 431:805-810.
3. Ashrafi G., Schwarz T.L. PINK1- and PARK2-mediated local mitophagy in distal neuronal axons. Autophagy 2015, 11:187-189.
4. Aylward E.H., Nopoulos P.C., Ross C.A., Langbehn D.R., Pierson R.K., Mills J.A., Johnson H.J., Magnotta V.A., Juhl A.R., Paulsen J.S., Investigators P.-H., Coordinators of Huntington Study, G. Longitudinal change in regional brain volumes in prodromal huntington disease. J. Neurol. Neurosurg. Psychiatry 2011, 82:405-410.
5. Baldo B., Soylu R., Petersen A. Maintenance of basal levels of autophagy in huntington's disease mouse models displaying metabolic dysfunction. PLoS ONE 2013, 8:e83050.
6. Birsa N., Norkett R., Wauer T., Mevissen T.E., Wu H.C., Foltynie T., Bhatia K., Hirst W.D., Komander D., Plun-Favreau H., Kittler J.T. Lysine 27 ubiquitination of the mitochondrial transport protein Miro is dependent on serine 65 of the Parkin ubiquitin ligase. J. Biol. Chem. 2014, 289:14569-14582.
7. Bolanos J.P., Almeida A., Moncada S. Glycolysis: a bioenergetic or a survival pathway?. Trends Biochem. Sci. 2010, 35:145-149.
8. Brustovetsky N., Brustovetsky T., Purl K.J., Capano M., Crompton M., Dubinsky J.M. Increased susceptibility of striatal mitochondria to calcium-induced permeability transition. J. Neurosci. 2003, 23:4858-4867.
9. Burté, F., Carelli, V., Chinnery, P.F., Yu-Wai-Man, P., 2015. Disturbed mitochondrial dynamics and neurodegenerative disorders. Nat. Rev. Neurol. 11, 11-24.
10. Chang C.R., Blackstone C. Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1. Ann. N. Y. Acad. Sci. 2010, 1201:34-39.
11. Chang D.T., Rintoul G.L., Pandipati S., Reynolds I.J. Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiol. Dis. 2006, 22:388-400.
12. Cho D.H., Nakamura T., Fang J., Cieplak P., Godzik A., Gu Z., Lipton S.A. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 2009, 324:102-105.
13. Choo Y.S., Johnson G.V., MacDonald M., Detloff P.J., Lesort M. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum. Mol. Genet. 2004, 13:1407-1420.
14. Costa V., Giacomello M., Hudec R., Lopreiato R., Ermak G., Lim D., Malorni W., Davies K.J., Carafoli E., Scorrano L. Mitochondrial fission and cristae disruption increase the response of cell models of huntington's disease to apoptotic stimuli. EMBO Mol. Med. 2010, 2:490-503.
15. Costa V., Scorrano L. Shaping the role of mitochondria in the pathogenesis of huntington's disease. EMBO J. 2012, 31:1853-1864.
16. Cui L., Jeong H., Borovecki F., Parkhurst C.N., Tanese N., Krainc D. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 2006, 127:59-69.
17. Damiano M., Diguet E., Malgorn C., D'Aurelio M., Galvan L., Petit F., Benhaim L., Guillermier M., Houitte D., Dufour N., Hantraye P., Canals J.M., Alberch J., Delzescaux T., Deglon N., Beal M.F., Brouillet E. A role of mitochondrial complex II defects in genetic models of huntington's disease expressing N-terminal fragments of mutant huntingtin. Hum. Mol. Genet. 2013, 22:3869-3882.
18. Diedrich M., Kitada T., Nebrich G., Koppelstaetter A., Shen J., Zabel C., Klose J., Mao L. Brain region specific mitophagy capacity could contribute to selective neuronal vulnerability in Parkinson's disease. Proteome Sci. 2011, 9:59.
19. Dubinsky J.M. Heterogeneity of nervous system mitochondria: location, location, location!. Exp. Neurol. 2009, 218:293-307.
20. DuBoff B., Feany M., Gotz J. Why size matters - balancing mitochondrial dynamics in Alzheimer's disease. Trends Neurosci. 2013, 36:325-335.
21. Ehrlich M.E. Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease. Neurotherapeutics 2012, 9:270-284.
22. Fimia G.M., Stoykova A., Romagnoli A., Giunta L., Di Bartolomeo S., Nardacci R., Corazzari M., Fuoco C., Ucar A., Schwartz P., Gruss P., Piacentini M., Chowdhury K., Cecconi F. Ambra1 regulates autophagy and development of the nervous system. Nature 2007, 447:1121-1125.
23. Francelle L., Galvan L., Brouillet E. Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in huntington's disease. Front. Cell. Neurosci. 2014, 8:295.
24. Fu M.M., Nirschl J.J., Holzbaur E.L. LC3 binding to the scaffolding protein JIP1 regulates processive dynein-driven transport of autophagosomes. Dev. Cell 2014, 29:577-590.
25. Gauthier L.R., Charrin B.C., Borrell-Pages M., Dompierre J.P., Rangone H., Cordelieres F.P., De Mey J., MacDonald M.E., Lessmann V., Humbert S., Saudou F. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 2004, 118:127-138.
26. Guedes-Dias P., de Proença J., Soares T.R., Leitão-Rocha A., Pinho B.R., Duchen M.R., Oliveira J.M. HDAC6 inhibition induces mitochondrial fusion, autophagic flux and reduces diffuse mutant huntingtin in striatal neurons. Biochim. Biophys. Acta 2015, 1852:2484-2493.
27. Guedes-Dias P., Oliveira J.M. Lysine deacetylases and mitochondrial dynamics in neurodegeneration. Biochim. Biophys. Acta 2013, 1832:1345-1359.
28. Guo X., Disatnik M.H., Monbureau M., Shamloo M., Mochly-Rosen D., Qi X. Inhibition of mitochondrial fragmentation diminishes huntington's disease-associated neurodegeneration. J. Clin. Invest. 2013, 123:5371-5388.
29. Gutekunst C.A., Li S.H., Yi H., Mulroy J.S., Kuemmerle S., Jones R., Rye D., Ferrante R.J., Hersch S.M., Li X.J. Nuclear and neuropil aggregates in huntington's disease: relationship to neuropathology. J. Neurosci. 1999, 19:2522-2534.
30. Harbauer A.B., Zahedi R.P., Sickmann A., Pfanner N., Meisinger C. The protein import machinery of mitochondria-a regulatory hub in metabolism, stress, and disease. Cell Metab. 2014, 19:357-372.
31. Haun F., Nakamura T., Shiu A.D., Cho D.H., Tsunemi T., Holland E.A., La Spada A.R., Lipton S.A. S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in huntington's disease. Antioxid. Redox Signal. 2013, 19:1173-1184.
32. HDCRG A novel gene containing a trinucleotide repeat that is expanded and unstable on huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993, 72:971-983.
33. Her L.S., Goldstein L.S. Enhanced sensitivity of striatal neurons to axonal transport defects induced by mutant huntingtin. J. Neurosci 2008, 28:13662-13672.
34. Hering T., Birth N., Taanman J.W., Orth M. Selective striatal mtDNA depletion in end-stage huntington's disease R6/2 mice. Exp. Neurol. 2015, 266:22-29.
35. Hinckelmann M.V., Zala D., Saudou F. Releasing the brake: restoring fast axonal transport in neurodegenerative disorders. Trends Cell Biol. 2013, 23:634-643.
36. Johri A., Chandra A., Beal M.F. PGC-1alpha, mitochondrial dysfunction, and huntington's disease. Free Radic. Biol. Med. 2013, 62:37-46.
37. Jonas E.A. Impaired import: how huntingtin harms. Nat. Neurosci. 2014, 17:747-749.
38. Kanki T., Furukawa K., Yamashita S.I. Mitophagy in yeast: Molecular mechanisms and physiological role. Biochim. Biophys. Acta 2015.
39. Khalil B., El Fissi N., Aouane A., Cabirol-Pol M.J., Rival T., Lievens J.C. PINK1-induced mitophagy promotes neuroprotection in huntington's disease. Cell Death Dis. 2015, 6:e1617.
40. Kim J., Moody J.P., Edgerly C.K., Bordiuk O.L., Cormier K., Smith K., Beal M.F., Ferrante R.J. Mitochondrial loss, dysfunction and altered dynamics in huntington's disease. Hum. Mol. Genet. 2010, 19:3919-3935.
41. Kuta A., Deng W., Morsi El-Kadi A., Banks G.T., Hafezparast M., Pfister K.K., Fisher E.M. Mouse cytoplasmic dynein intermediate chains: identification of new isoforms, alternative splicing and tissue distribution of transcripts. PLoS ONE 2010, 5.
42. Kuznetsov A.V., Hermann M., Saks V., Hengster P., Margreiter R. The cell-type specificity of mitochondrial dynamics. Int. J. Biochem. Cell Biol. 2009, 41:1928-1939.
43. Le Grand J.N., Bon K., Fraichard A., Zhang J., Jouvenot M., Risold P.Y., Boyer-Guittaut M., Delage-Mourroux R. Specific distribution of the autophagic protein GABARAPL1/GEC1 in the developing and adult mouse brain and identification of neuronal populations expressing GABARAPL1/GEC1. PLoS ONE 2013, 8.
44. Lee S., Sato Y., Nixon R.A. Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy. J. Neurosci. 2011, 31:7817-7830.
45. Leitão-Rocha A., Guedes-Dias P., Pinho B.R., Oliveira J.M. Trends in mitochondrial therapeutics for neurological disease. Curr. Med. Chem. 2015, 22:2458-2467.
46. Li X.J., Li S.H., Sharp A.H., Nucifora F.C., Schilling G., Lanahan A., Worley P., Snyder S.H., Ross C.A. A huntingtin-associated protein enriched in brain with implications for pathology. Nature 1995, 378:398-402.
47. Lin J., Wu P.H., Tarr P.T., Lindenberg K.S., St-Pierre J., Zhang C.Y., Mootha V.K., Jager S., Vianna C.R., Reznick R.M., Cui L., Manieri M., Donovan M.X., Wu Z., Cooper M.P., Fan M.C., Rohas L.M., Zavacki A.M., Cinti S., Shulman G.I., Lowell B.B., Krainc D., Spiegelman B.M. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 2004, 119:121-135.
48. Liot G., Zala D., Pla P., Mottet G., Piel M., Saudou F. Mutant huntingtin alters retrograde transport of TrkB receptors in striatal dendrites. J. Neurosci. 2013, 33:6298-6309.
49. MacAskill A.F., Kittler J.T. Control of mitochondrial transport and localization in neurons. Trends Cell Biol. 2010, 20:102-112.
50. Maday S., Holzbaur E.L. Autophagosome biogenesis in primary neurons follows an ordered and spatially regulated pathway. Dev. Cell 2014, 30:71-85.
51. Maday S., Wallace K.E., Holzbaur E.L. Autophagosomes initiate distally and mature during transport toward the cell soma in primary neurons. J. Cell Biol. 2012, 196:407-417.
52. Margulis J., Finkbeiner S. Proteostasis in striatal cells and selective neurodegeneration in Huntington's disease. Front. Cell. Neurosci. 2014, 8:218.
53. Martinez-Vicente M., Talloczy Z., Wong E., Tang G., Koga H., Kaushik S., de Vries R., Arias E., Harris S., Sulzer D., Cuervo A.M. Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease. Nat. Neurosci. 2010, 13:567-576.
54. Mealer R.G., Murray A.J., Shahani N., Subramaniam S., Snyder S.H. Rhes, a striatal-selective protein implicated in Huntington disease, binds beclin-1 and activates autophagy. J. Biol. Chem. 2014, 289:3547-3554.
55. Meisinger C., Sickmann A., Pfanner N. The mitochondrial proteome: from inventory to function. Cell 2008, 134:22-24.
56. Mick D.U., Dennerlein S., Wiese H., Reinhold R., Pacheu-Grau D., Lorenzi I., Sasarman F., Weraarpachai W., Shoubridge E.A., Warscheid B., Rehling P. MITRAC links mitochondrial protein translocation to respiratory-chain assembly and translational regulation. Cell 2012, 151:1528-1541.
57. Mishra P., Chan D.C. Mitochondrial dynamics and inheritance during cell division, development and disease. Nat. Rev. Mol. Cell Biol. 2014, 15:634-646.
58. Ney P.A. Mitochondrial autophagy: origins, significance, and role of BNIP3 and NIX. Biochim. Biophys. Acta 2015, 1853:2775-2783.
59. Ni H.M., Williams J.A., Ding W.X. Mitochondrial dynamics and mitochondrial quality control. Redox. Biol. 2015, 4:6-13.
60. Ochaba J., Lukacsovich T., Csikos G., Zheng S., Margulis J., Salazar L., Mao K., Lau A.L., Yeung S.Y., Humbert S., Saudou F., Klionsky D.J., Finkbeiner S., Zeitlin S.O., Marsh J.L., Housman D.E., Thompson L.M., Steffan J.S. Potential function for the Huntingtin protein as a scaffold for selective autophagy. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:16889-16894.
61. Oliveira J.M. Mitochondrial bioenergetics and dynamics in Huntington's disease: tripartite synapses and selective striatal degeneration. J. Bioenerg. Biomembr. 2010, 42:227-234.
62. Oliveira J.M. Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum. J. Neurochem. 2010, 114:1-12.
63. Oliveira J.M. Techniques to investigate neuronal mitochondrial function and its pharmacological modulation. Curr. Drug Targets 2011, 12:762-773.
64. Oliveira J.M., Chen S., Almeida S., Riley R., Gonçalves J., Oliveira C.R., Hayden M.R., Nicholls D.G., Ellerby L.M., Rego A.C. Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors. J. Neurosci. 2006, 26:11174-11186.
65. Oliveira J.M., Gonçalves J. In situ mitochondrial Ca2+ buffering differences of intact neurons and astrocytes from cortex and striatum. J. Biol. Chem. 2009, 284:5010-5020.
66. Oliveira J.M., Lightowlers R.N. Could successful (mitochondrial) networking help prevent Huntington's disease?. EMBO Mol. Med. 2010, 2:487-489.
67. Orr A.L., Li S., Wang C.E., Li H., Wang J., Rong J., Xu X., Mastroberardino P.G., Greenamyre J.T., Li X.J. N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J. Neurosci. 2008, 28:2783-2792.
68. Otera H., Mihara K. Molecular mechanisms and physiologic functions of mitochondrial dynamics. J. Biochem. 2011, 149:241-251.
69. Pagliarini D.J., Calvo S.E., Chang B., Sheth S.A., Vafai S.B., Ong S.E., Walford G.A., Sugiana C., Boneh A., Chen W.K., Hill D.E., Vidal M., Evans J.G., Thorburn D.R., Carr S.A., Mootha V.K. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008, 134:112-123.
70. Panov A.V., Gutekunst C.A., Leavitt B.R., Hayden M.R., Burke J.R., Strittmatter W.J., Greenamyre J.T. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci. 2002, 5:731-736.
71. Paulsen J.S., Nopoulos P.C., Aylward E., Ross C.A., Johnson H., Magnotta V.A., Juhl A., Pierson R.K., Mills J., Langbehn D., Nance M., Investigators P.-H., Coordinators of the Huntington's Study, G. Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res. Bull. 2010, 82:201-207.
72. Pickrell A.M., Fukui H., Wang X., Pinto M., Moraes C.T. The striatum is highly susceptible to mitochondrial oxidative phosphorylation dysfunctions. J. Neurosci. 2011, 31:9895-9904.
73. Pickrell A.M., Youle R.J. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease. Neuron 2015, 85:257-273.
74. Plotkin J.L., Day M., Peterson J.D., Xie Z., Kress G.J., Rafalovich I., Kondapalli J., Gertler T.S., Flajolet M., Greengard P., Stavarache M., Kaplitt M.G., Rosinski J., Chan C.S., Surmeier D.J. Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease. Neuron 2014, 83:178-188.
75. Plotkin J.L., Surmeier D.J. Corticostriatal synaptic adaptations in Huntington's disease. Curr. Opin. Neurobiol. 2015, 33C:53-62.
76. Puddifoot C., Martel M.A., Soriano F.X., Camacho A., Vidal-Puig A., Wyllie D.J., Hardingham G.E. PGC-1alpha negatively regulates extrasynaptic NMDAR activity and excitotoxicity. J. Neurosci 2012, .32:6995-7000.
77. Qi X., Qvit N., Su Y.C., Mochly-Rosen D. A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J. Cell Sci. 2013, 126:789-802.
78. Reddy P.H., Shirendeb U.P. Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease. Biochim. Biophys. Acta 2012, 1822:101-110.
79. Ross C.A., Tabrizi S.J. Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 2011, 10:83-98.
80. Rui Y.N., Xu Z., Patel B., Chen Z., Chen D., Tito A., David G., Sun Y., Stimming E.F., Bellen H.J., Cuervo A.M., Zhang S. Huntingtin functions as a scaffold for selective macroautophagy. Nat. Cell Biol. 2015, 17:262-275.
81. Scarpulla R.C. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim. Biophys. Acta 2011, 1813:1269-1278.
82. Schmidt O., Pfanner N., Meisinger C. Mitochondrial protein import: from proteomics to functional mechanisms. Nat. Rev. Mol. Cell Biol. 2010, 11:655-667.
83. Schulz C., Schendzielorz A., Rehling P. Unlocking the presequence import pathway. Trends Cell Biol. 2015, 25:265-275.
84. Schwarz T.L. Mitochondrial trafficking in neurons. Cold Spring Harb. Perspect. Biol. 2013, 5:a011304.
85. Seneca S., Fagnart D., Keymolen K., Lissens W., Hasaerts D., Debulpaep S., Desprechins B., Liebaers I., De Meirleir L. Early onset Huntington disease: a neuronal degeneration syndrome. Eur. J. Pediatr. 2004, 163:717-721.
86. Sepe S., Nardacci R., Fanelli F., Rosso P., Bernardi C., Cecconi F., Mastroberardino P.G., Piacentini M., Moreno S. Expression of Ambra1 in mouse brain during physiological and Alzheimer type aging. Neurobiol. Aging 2014, 35:96-108.
87. Sepers M.D., Raymond L.A. Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease. Drug Discov. Today 2014, 19:990-996.
88. Shi R.Y., Zhu S.H., Li V., Gibson S.B., Xu X.S., Kong J.M. BNIP3 interacting with LC3 triggers excessive mitophagy in delayed neuronal death in stroke. CNS Neurosci. Ther. 2014, 20:1045-1055.
89. Shirendeb U., Reddy A.P., Manczak M., Calkins M.J., Mao P., Tagle D.A., Reddy P.H. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage. Hum. Mol. Genet. 2011, 20:1438-1455.
90. Shirendeb U.P., Calkins M.J., Manczak M., Anekonda V., Dufour B., McBride J.L., Mao P., Reddy P.H. Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease. Hum. Mol. Genet. 2012, 21:406-420.
91. Smirnova E., Griparic L., Shurland D.L., van der Bliek A.M. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol. Biol. Cell 2001, 12:2245-2256.
92. Song W., Chen J., Petrilli A., Liot G., Klinglmayr E., Zhou Y., Poquiz P., Tjong J., Pouladi M.A., Hayden M.R., Masliah E., Ellisman M., Rouiller I., Schwarzenbacher R., Bossy B., Perkins G., Bossy-Wetzel E. Mutant Huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat. Med. 2011, 17:377-382.
93. Subramaniam S., Sixt K.M., Barrow R., Snyder S.H. Rhes, a striatal specific protein, mediates mutant-Huntingtin cytotoxicity. Science 2009, 324:1327-1330.
94. Tanaka A., Cleland M.M., Xu S., Narendra D.P., Suen D.F., Karbowski M., Youle R.J. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J. Cell Biol. 2010, 191:1367-1380.
95. Trushina E., Dyer R.B., Badger J.D., Ure D., Eide L., Tran D.D., Vrieze B.T., Legendre-Guillemin V., McPherson P.S., Mandavilli B.S., Van Houten B., Zeitlin S., McNiven M., Aebersold R., Hayden M., Parisi J.E., Seeberg E., Dragatsis I., Doyle K., Bender A., Chacko C., McMurray C.T. Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol. Cell. Biol. 2004, 24:8195-8209.
96. Tsvetkov A.S., Arrasate M., Barmada S., Ando D.M., Sharma P., Shaby B.A., Finkbeiner S. Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration. Nat. Chem. Biol. 2013, 9:586-592.
97. Tsvetkov A.S., Miller J., Arrasate M., Wong J.S., Pleiss M.A., Finkbeiner S. A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:16982-16987.
98. van Spronsen M., Mikhaylova M., Lipka J., Schlager M.A., van den Heuvel D.J., Kuijpers M., Wulf P.S., Keijzer N., Demmers J., Kapitein L.C., Jaarsma D., Gerritsen H.C., Akhmanova A., Hoogenraad C.C. TRAK/milton motor-adaptor proteins steer mitochondrial trafficking to axons and dendrites. Neuron 2013, 77:485-502.
99. Walker F.O. Huntington's disease. Lancet 2007, 369:218-228.
100. Wang X., Winter D., Ashrafi G., Schlehe J., Wong Y.L., Selkoe D., Rice S., Steen J., LaVoie M.J., Schwarz T.L. PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 2011, 147:893-906.
101. Weydt P., Pineda V.V., Torrence A.E., Libby R.T., Satterfield T.F., Lazarowski E.R., Gilbert M.L., Morton G.J., Bammler T.K., Strand A.D., Cui L., Beyer R.P., Easley C.N., Smith A.C., Krainc D., Luquet S., Sweet I.R., Schwartz M.W., La Spada A.R. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Cell Metab. 2006, 4:349-362.
102. Wong Y.C., Holzbaur E.L. The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation. J. Neurosci. 2014, 34:1293-1305.
103. Xiang J., Yang H., Zhao T., Sun M., Xu X., Zhou X.F., Li S.H., Li X.J. Huntingtin-associated protein 1 regulates postnatal neurogenesis and neurotrophin receptor sorting. J. Clin. Invest. 2014, 124:85-98.
104. Yano H., Baranov S.V., Baranova O.V., Kim J., Pan Y., Yablonska S., Carlisle D.L., Ferrante R.J., Kim A.H., Friedlander R.M. Inhibition of mitochondrial protein import by mutant huntingtin. Nat. Neurosci. 2014, 17:822-831.
105. Youle R.J., van der Bliek A.M. Mitochondrial fission, fusion, and stress. Science 2012, 337:1062-1065.
106. Yu Z.X., Li S.H., Evans J., Pillarisetti A., Li H., Li X.J. Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease. J. Neurosci. 2003, 23:2193-2202.
107. Zhang L., Liu C., Wu J., Tao J.J., Sui X.L., Yao Z.G., Xu Y.F., Huang L., Zhu H., Sheng S.L., Qin C. Tubastatin A/ACY-1215 improves cognition in Alzheimer's disease transgenic mice. J. Alzheimers Dis. 2014, 41:1193-1205.
108. Zuccato C., Cattaneo E. Role of brain-derived neurotrophic factor in Huntington's disease. Prog. Neurobiol. 2007, 81:294-330.
109. Zuccato C., Valenza M., Cattaneo E. Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiol. Rev. 2010, 90:905-981.